AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

HPV-16 recurrence is associated with differing T cell response to L1 and E7.

Women's Health Weekly

| August 07, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 AUG 7 - (NewsRx.com & NewsRx.net) -- Specific T cell responses to HPV-16 proteins L1 and E7 are associated with different disease states and recurrence.

"Human papillomavirus type 16 (HPV-16) L1 and E7 specific T cell responses were measured in 58 women with abnormal cervical cytology in a prospective study. On recruitment, patients responded most frequently and with the highest numbers of responding cells to the L1 region, aa 311-345, and this response was significantly associated with the presence of cervical disease," researchers in England report.

"Responses to the L1 peptide aa 281-295 were significantly higher in patients with CIN III than in those with HPV/CIN I or CIN II lesions (p=0.027). The E7 region aa 70-98 was most immunogenic in patients with squamous intraepithelial lesions of the cervix (SIL) but the responses detected were not significantly higher than in patients without SIL. Following treatment, the T cell response profiles of patient groups did not change significantly. However, on analysis of the responses of individual patients with and without recurrent disease on followup, significant differences were found," wrote J.C. Luxton and coworkers.

The researchers concluded: "Recurrence of disease was associated with T cell responses to the E7 region aa 70-98 at the first clinic visit ...

Related articles from newspapers, magazines, journals, and more
Transgene Initiates Phase II Clinical Trial With Its MVA-HPV-IL2 Product for...
Press release article from: PR Newswire October 18, 2001 700+ words
...uses the MVA virus to express two HPV antigens found in HPV 16, the E6 and E7 proteins...included to help stimulate specific T cell responses. The purpose of treating cervical cancer patients with MVA-HPV-IL2 is to induce an efficient...
Experimental HPV vaccine shows promise.(Infectious Diseases)(Clinical report)
Magazine article from: Skin & Allergy News Worcester, Sharon May 1, 2008 700+ words
...study of 20 women with HPV-16 positive vulvar...resulted in important T-cell responses in most patients after...cytokine profile of the HPV-16-specific memory T-cell responses observed in healthy...the VIN lesion by HPV-16-specific Th1...
Xenova Group plc: Successful Results of Phase IIa and Phase I HPV-Related...
Press release article from: PR Newswire October 26, 2001 700+ words
...IIa trial of Xenova's TA-HPV vaccine in women with high grade...risk human papillomavirus (HPV) associated condition. The...antibody responses, and positive T cell responses were seen in all of the cohorts...demonstrated that a combination of TA-HPV and TA-CIN results in an immune...
Transgene Moves Forward Its Vaccine Candidate MVA-HPV-IL2 In A Novel Approach...
Press release article from: PR Newswire November 30, 2004 700+ words
...cancer vaccine Transgene's MVA-HPV-IL2 product candidate uses the MVA virus to carry and express two HPV antigens found in HPV 16, the E6 and E7 proteins...included to help stimulate specific T cell responses. About Transgene Transgene...
Nventa presents HspE7 data at international HPV conference.
Press release article from: PR Newswire November 5, 2007 700+ words
...Hsp65) linked to the E7 protein of HPV type 16, when combined with the TLR3...inducing potent E7-specific CD8 T cell responses (cellular responses) and regressing...caused by the human papillomavirus (HPV), one of the most common sexually...
HPV-11 early protein E6 dominant inducer of cytokine expression in RRP.
Newspaper article from: Respiratory Therapeutics Week August 2, 2004 700+ words
...immunospot assay. "These studies show that HPV-11 E6 skews IL-10-IFN-gamma expression...cytokine microenvironment unfavorable to HPV-specific, T-cell responses that should control persistent HPV infection." Scientists concluded, "In...
Kunjin virus replicon vaccine protects against HPV-expressing tumor.
Newspaper article from: Cancer Weekly April 27, 2004 700+ words
...oncoprotein in transformed cells in human papillomavirus (HPV)-associated cervical cancer provides a tumor-specific...polyepitope encoded by a KUN vector induced E7-directed T-cell responses and protected mice against challenge with an E7-expressing...
HPV genotyping prior to vaccination holds promise.(human papillomavirus...
Magazine article from: Medical Laboratory Observer Kim, Jong-Kee March 1, 2009 700+ words
...American Social Health Association reports that HPV is one of the most common STDs in the United States. According to HPV Vaccine Statement published by the Centers...year. The good news is that most genital HPV infections are easily treated and clear...
For more facts and information, see all results

Source: HighBeam Research, HPV-16 recurrence is associated with differing T cell response to L1...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA